Is Ocugen's Surge Much Ado About Nothing?

Ocugen (NASDAQ: OCGN) stock enjoyed a big run-up as investors awaited a decision by the World Health Organization (WHO) on Emergency Use Listing (EUL) for COVID-19 vaccine Covaxin. In this Motley Fool Live video recorded on Oct. 27, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not Ocugen's recent surge is much ado about nothing.

Continue reading

Source Fool.com